Fredag 9 Maj | 23:03:13 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2025-11-21 08:20 Kvartalsrapport 2025-Q3
2025-08-21 08:20 Kvartalsrapport 2025-Q2
2025-05-22 N/A X-dag ordinarie utdelning RAYTL 0.00 SEK
2025-05-21 N/A Årsstämma
2025-05-21 08:20 Kvartalsrapport 2025-Q1
2025-02-20 - Bokslutskommuniké 2024
2024-12-16 - Extra Bolagsstämma 2025
2024-10-30 - Kvartalsrapport 2024-Q3
2024-09-27 - Extra Bolagsstämma 2024
2024-08-22 - Kvartalsrapport 2024-Q2
2024-06-14 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2024-06-13 - Årsstämma
2024-05-28 - Split RAYTL 100:1
2024-05-23 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-11-24 - Extra Bolagsstämma 2023
2023-11-23 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-25 - Kvartalsrapport 2023-Q1
2023-05-03 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2023-05-02 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-30 - Kvartalsrapport 2022-Q3
2022-10-07 - Extra Bolagsstämma 2022
2022-08-26 - Kvartalsrapport 2022-Q2
2022-05-13 - Kvartalsrapport 2022-Q1
2022-04-19 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2022-04-18 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-27 - Kvartalsrapport 2021-Q1
2021-04-20 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2021-04-19 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-11-27 - Kvartalsrapport 2020-Q3
2020-10-20 - Extra Bolagsstämma 2020
2020-08-27 - Kvartalsrapport 2020-Q2
2020-05-27 - Kvartalsrapport 2020-Q1
2020-04-21 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2020-04-20 - Årsstämma
2020-02-27 - Bokslutskommuniké 2019
2019-10-21 - Kvartalsrapport 2019-Q3
2019-04-23 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2019-04-18 - Årsstämma
2019-02-19 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorHälsovård
IndustriMedicinteknik
Raytelligence är ett investeringsbolag. Bolagets nyckelstrategi är att identifiera och slutföra en kombination med en verksamhet inom någon av följande sektorer fordonsindustri, finansiella tjänster, livsmedelsteknik, hälsovård, spjutspetsteknologi och mediasektorer, även om företaget förbehåller sig rätten att utöva en förvärvsmöjlighet i alla företag eller branscher. Verksamheten bedrivs i Europa och Asien, och huvudkontoret ligger i Stockholm.
2025-04-16 18:00:00

The Board of Directors of Raytelligence AB has appointed Robert Grinberg as new CEO. 

 

The Board of Directors of Raytelligence AB has today appointed Robert Grinberg as the new CEO, following the untimely passing of Ben Hedenberg.

 

Grinberg has been a member of the Board of Directors of the company since 2024. Grinberg is a highly motivated leader with over 25 years of experience evaluating, growing and leading start-ups in various industries; including automotive, biotechnology, blockchain, brokerage, compliance, golf equipment, healthcare, medical marijuana, mental health, oil and gas, risk management, technology and trading.

 

Robert has experience in leveraging extensive business expertise and successfully helping organizations thrive in changing and competitive markets by achieving growth goals through investments, strategies, mergers, acquisitions, joint ventures and strategic partnerships.

 

The Board is applying for an exemption from the residency requirement with the Swedish Companies Registration Office and will seek a permanent CEO in the spring.

 

 

 

For further information, please contact:

Robert Grinberg, CEO
Tel: +1 
561 302 2787
E-post:
robertgrinberg27@gmail.com

 

Sven Otto Littorin, Chairman of the Board
Phone: +46 70 287 4775
E-Post:
littorin@gibranassociates.com

 

 

 

This information is information that Raytelligence AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 18:00 CET on 16 April 2025.

 

 

About Raytelligence

The company's key strategy is to identify and finalise a combination with a business in any of the following sectors biotechnology & pharmaceuticals, automotive, financial services, communications technology, food technology, cutting edge technologies and media sectors in Europe, America and Asia that can benefit from our management team's extensive experience and operational capability, although the company reserves the right to exercise an acquisition option in any company or industry.